⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Tumor Microenvironment Market to Reach Over $2.7 Billion by 2030 - Rising Demand for Personalized Oncology Therapies and Next-Gen Immunotherapies Driving the Industry
globenewswire.com
PFE
JNJ
MRK
ABBV
CHRS
Global Virus Network Meeting Advances a Science-Driven Agenda for Pandemic Preparedness
globenewswire.com
PFE
MRK
JNJ
BMY
GILD
Next-Gen Oncology Devices and Solutions Market to Double by 2030, Reaching Over $38 Billion
globenewswire.com
JNJ
MRK
GEHC
HOLX
Metastatic Lung Adenocarcinoma Treatment Market Outlook Report 2026-2030: Targeted Therapies Fuel Growth, with Revenues Reaching $5 Billion by 2030
globenewswire.com
PFE
JNJ
MRK
BMY
Head and Neck Cancer Market to Expand at 7.8% CAGR During 2026-2030 as Immuno-Oncology Therapies Offer Promising Advances in HNC Treatments
globenewswire.com
PFE
MRK
AZN
CHRS
Adrenocortical Carcinoma Market Report 2026: Innovative Therapies Set to Transform the $4 Billion Adrenocortical Carcinoma Landscape
globenewswire.com
MRK
AZN
LLY
SNY
Glioblastoma Multiforme Market Intelligence Report 2026-2030 & 2035: Advanced Targeted Drugs Propel Industry Growth
globenewswire.com
PFE
ABBV
BMY
AZN
MRK
Head and Neck Squamous Cell Carcinoma Market Forecast to 2030 & 2035
globenewswire.com
EXEL
MRK
PFE
BMY
AZN
NCCN Foundation Announces Annual Awards to Support Future Leaders for Cancer Innovation
prnewswire.com
EXEL
MRK
PFE
Gliosarcoma Market Intelligence Report 2026-2030 & 2035: Expansion of Molecular Testing and Increased Research Funding is Driving Industry Growth
globenewswire.com
NVCR
MRK
PFE
ABBV